- R&D Pipeline
- Season 2 (2021-2030)
| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Recombinant human HAPLN1 protein: a multi-functional therapeutic candidate to treat dry eye disease | ||||||
| Recombinant Protein | Dry eye disease | HAPLN1 | Candidate | HaplnScience Inc. | RS-2023-00217306 | ||
| 2 | Development of gene therapeutics targeting EYS-related Retinitis Pigmentosa | ||||||
| Recombinant Protein | Retinitis pigmentosa | EYS c.4957dupA | Hit | Sungkyunkwan University | HN22C0571 | ||